Eduard Puente‐Massaguer

Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses

Meagan McMahon, George O’Dell, Jessica Tan et al. · Proceedings of the National Academy of Sciences · 2022 · 77 citations · Full text

Vaccination, Cross-protection, Group 2 +15

Quality Assessment of Virus-Like Particles at Single Particle Level: A Comparative Study

Irene González‐Domínguez, Eduard Puente‐Massaguer, Laura Cervera et al. · Viruses · 2020 · 48 citations · Full text

Engineering, Viral Diagnostics, Immunology +18

Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in mice

Eduard Puente‐Massaguer, Kirill Vasilev, A. Beyer et al. · Science Advances · 2023 · 30 citations · Full text

Immunology, Cd4 T Cell Responses, Flu Vaccination +16

Stability enhancement of clinical grade multipotent mesenchymal stromal cell-based products

Clémentine Mirabel, Eduard Puente‐Massaguer, Anna del Mazo-Barbara et al. · Journal of Translational Medicine · 2018 · 29 citations · Full text

A statistical approach to improve compound screening in cell culture media

Eduard Puente‐Massaguer, Llorenç Badiella, Sònia Gutiérrez-Granados et al. · Engineering in Life Sciences · 2019 · 25 citations · Full text